Ionis Pharmaceuticals, Inc. · NASDAQ:IONS
The Vanguard Group reported a 10.43% stake in Ionis Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 8, 2025
The Vanguard Group reported a 10.43% stake in Ionis Pharmaceuticals, Inc., 16,472,539 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G/A).
- Stake
- 10.43%
- Shares
- 16,472,539
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.43% | 16,472,539 |
Source
Related
- Ionis Pharmaceuticals, Inc.
- The Vanguard Group
- Ionis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Devers Shannon L. · Oct 19, 2026
- Form 4 · Swayze Eric · Oct 19, 2026
- Form 4 · Bennett C Frank · Sep 2, 2026
- Form 4 · O'Neil Patrick R. · Sep 2, 2026
- Form 4 · Monia Brett P · Sep 2, 2026